Delivery Order SPE2DR25D6028-SPE2DR26FASKR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $1,311.28. This is a firm fixed price delivery order with an ultimate completion date of November 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Clindamycin PH 1% Solution in 60ml quantities, valued at $2,454.60 with completion targeted for November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,234.84 to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 mL in 50 mL vials. This is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $2,117.43 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,277.84 award is for the supply of CLINDAMYCIN 900 MG/50 ML-D5W 50ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp, operating out of Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which does not have a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, with a ceiling value of $3,750.83 and a completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Clindamycin (pediatric formulation) 75 mg/5 ml in 100 ml quantities, with a ceiling value of $1,865.88. This firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures with no set-aside designation,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 900 mg/6 ml vials on June 17, 2025, with a ceiling value of $1,347.33. This is a firm fixed-price delivery order with an ultimate completion date of June 18, 2025, reflecting the time-sensitive nature of pharmaceutical procurement for military and federal healthcare operations. The contract carries no set-aside designation, indicating it was awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Clindamycin 600 mg/50 mL in dextrose 5% water solution with a firm fixed price ceiling value of $1,045.64. This is a non-set-aside competitive award with an ultimate completion date of December 4, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Clindamycin 600 mg/50 ml in D5W solution with a ceiling value of $1,210.80 and an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASKRDelivery Order
The Defense Logistics Agency awarded a $1,829.11 delivery order to AmerisourceBergen Drug Corp for Clindamycin Palmitate, an antibiotic pharmaceutical product. This firm fixed price delivery order, issued on December 5, 2025, is scheduled for completion by January 5, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive set-aside arrangement, reflecting AmerisourceBergen's established position as a critical federal pharmaceutical supplier. This delivery order is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare operations worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains extensive federal contract portfolio serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a key vendor for military and veteran medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/4/25 |